H2020Individual fellowship2018–2019

DropContEvo · A droplet microfluidic system for continuous in vivo evolution.

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2018-01-01 → 2019-12-31
EU contribution
€183,455
Participants
1
Scheme
MSCA-IF-EF-ST

Lines connect the coordinator with its partners.

Results in brief

A droplet microfluidic system for continuous in vivo evolution.

Directed evolution is now arguably the method of choice for improvement of proteins used in applications ranging from washing powders to fine chemicals and medical applications. Screening and selection of improved variants is widely used both in the research laboratories as well in industry towards improved activity, selectivity and stability of relevant biomolecules. Directed evolution has gained well-deserved recognition in 2018 when the Nobel Prize in Chemistry was awarded to researchers who developed laboratory approaches for discovery of enzymes and biotherapeutics. However, screening and selection of mutated variants of enzymes is currently performed mainly in low or moderate throughput and often uses liquid chromatography and mass spectrometry for detection of the reaction output. Implementation of these screening methods is costly and usually requires substantial investments both on laboratory and on industrial scales. Droplet microfluidics offers an unprecedented increase in the screening throughput of reactions that can be measured within a single day and using greatly reduced volumes of reagents. The analysis of the enzymatic activity in a microdroplet format requires capturing of the reaction product and the cell together in microcompartments to maintain the genotype-phenotype linkage. Recently it has become possible to generate pico-litre volume water-in-oil droplets containing single cells, incubate them and sort them in high throughput. However, a microfluidics approach is partially compromised by technical limitations of microfluidic modules, limited choice of methods of optical readouts of the reaction outcome and general low accessibility to non-specialized researchers. Microdroplet technologies so far have been used only for limited number of reactions, usually using non-natural bait substrates and with limited success. This project aimed at development of new microfluidic modules and strategies dedicated mainly for in-vivo directed evolution. Experimental laboratory evolution must comprise four key steps: mutation, gene expression, selection, and replication. The key to success is the ability to handle the enormous combinatorial diversity that randomization of the amino acids of protein brings about. From the point of view of development of microfluidic technology, the project aimed at development of novel and highly reliable microfluidic modules for long long-term and unsupervised experiments involving multiple operations on a single chip - e.g. generation of droplets, cultivation of microorganisms in hundreds of thousands of picoliter droplets, picoinjection of substrates or nutrients, splitting of droplets and high-throughput sorting. The second objective of the project was to test and develop new enzymatic assays and alternative formats of protein expression in microdroplet format. One of such alternative is to use whole cell microdroplet assays combined with microbial growth towards the in vivo continuous evolution.

Data: CORDIS, © European Union

Project objective

Droplet microfluidics has recently become one of the breakthrough technologies for high throughput screening in microbiology and biochemistry, including single cell studies and new approaches to in vitro evolution. Here we propose a development of a novel microfluidic system for unsupervised execution of multiple cycles of in vivo continuous evolution in hundreds of thousands of picoliter droplets. Each evolutionary cycle will comprise: i) encapsulation of single bacteria cells in water-in-oil compartments ii) growth of the cells coupled with production of economically relevant biomolecules iii) selection of the most efficient populations using ultra-high-throughput sorting of picodroplets, iv) dilution of each population via merging with 100 times larger nanoliter droplet containing fresh nutrients and v) passive splitting of each of the resulting nanoliter droplets to the libraries of picoliter droplets containing single cells. Confinement of the reaction in small volume and active sorting of droplets will facilitate and accelerate the process of in vivo evolution. Droplet format will also enable for various screening schemes, so far not available for continuous evolution strategies – e.g. based on high throughput fluorescence or absorbance measurements of the droplet content. The second stage of the project will comprise a series of proof-of-concept experiments presenting directed continuous evolution of the tryptophan synthase (TrpS) in E.coli bacteria. The technology proposed here would be very useful for broad community of biotechnologists, evolutionary biologists and industrial specialists without the experience in microfluidics. The proposed research will be conducted at Dr. Hollfelder´s laboratory that specializes in directed evolution of enzymes and application of microfluidics to industrial biotechnology. The project comprise broad and extensive training in research and complementary soft skills that will aid professional development of the Beneficiary.

Original text from CORDIS.

Participants

  • THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE · CAMBRIDGECoordinatorUnited Kingdom

Links

Data: CORDIS, © European Union